Nephrxn Pharmaceuticals

Nephrxn Pharmaceuticals is a biotechnology company dedicated to the discovery and development of first-in-class therapeutics for the treatment of kidney diseases. The company focuses on leveraging growth factor signaling pathways to promote the repair and regeneration of renal tissues following injury. Its primary research programs target acute kidney injury (AKI) and chronic kidney disease (CKD), aiming to address significant unmet medical needs in nephrology. By developing small molecules and peptides that modulate specific cellular receptors, Nephrxn seeks to prevent the progression of renal failure and improve patient outcomes in conditions like diabetic nephropathy.